Global Rapid Tests Market is valued approximately USD 1.19 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.60% over the forecast period 2022-2029 Rapid tests, commonly referred to as RDTs or rapid diagnostic tests, are simple to use procedures that offer prompt answers, typically in few minutes or less. Rapid tests are performed and give results at the point of treatment, unlike the majority of regular tests, which must be forwarded to a lab. The Rapid Tests market is expanding because of factors such as increasing adoption of Self - Testing & Point - Of - Care Products, and introduction Of CLIA Waived Test and growing Geriatric Population Base. However, the presence of ambiguous regulatory may halt market growth.
Diabetes is one of the world's fastest-growing chronic diseases. Its prevalence has progressively increased during the last few decades. The primary factors propelling market expansion are the rising elderly population, increasing target disease burden, and increased usage of self-testing & point-of-care products. According to the World Health Organization, diabetes will afflict 537 million adults globally in 2021, with one in ten experiencing other diabetes. Furthermore, geriatric, and obese populations are predisposed to chronic diseases. According to the World Bank Group, the world old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. Additionally, the market is expanding as a result of the introduction of technologically advanced items. However, the main difficulty with quick diagnostics solutions is quality assurance, which is expected to limit market expansion.
The key regions considered for the Global Rapid Tests Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the emergence of technologically advanced products, high rates of infections with upper respiratory diseases and antibiotic resistance, and high healthcare costs Additionally, the usage of PoC & fast diagnostics for the diagnosis of numerous ailments in the region, as well as encouraging government initiatives, are supporting the market's expansion. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market players included in this report are:
- Abbott
- BD (Becton, Dickinson and Company)
- bioMerieux SA
- DiaSorin S.p.A.
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- F. Hoffmann - La Roche Ltd
- Meridian Bioscience, Inc.
- Bio-rad Laboratories, Inc.
Recent Developments in the Market:
- In August 2022, Accelerate Diagnostics and BD collaborated commercially. Through this strategic strategy, BD would provide Accelerate Diagnostics' quick diagnostics for antibiotic resistance and susceptibility over the world.
- In December 2022, Roche stated that the U.S. Food and Drug Administration had authorised the COVID-19 At-home Test for Emergency Use. The test involves a straightforward anterior nasal swab sample that may be easily obtained and self-tested by those age 14 and older. For children aged 2 to 13, an adult must administer the test.
Global Rapid Tests Market Report Scope:
- Historical Data: 2019-2020-2021
- Base Year for Estimation: 2021
- Forecast period: 2022-2029
- Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: Product, Technology, Application, , End Use, Region
- Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
- Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.
By Product:
- Instruments
- Consumables
- Others
By Technology:
- Molecular Diagnostics
- Immunoassay
- Others
By Application:
- Upper Respiratory Tract Infections
- Antibiotic
- Sepsis
By End Use:
- Hospitals & Clinics
- Laboratories
- At - Home Testing
- Others
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- RoLA
- Rest of the World
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Rapid Tests Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Rapid Tests Market, by Product, 2019-2029 (USD Billion)
- 1.2.3. Rapid Tests Market, by Technology, 2019-2029 (USD Billion)
- 1.2.4. Rapid Tests Market, by Application, 2019-2029 (USD Billion)
- 1.2.5. Rapid Tests Market, by End Use, 2019-2029 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Rapid Tests Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Rapid Tests Market Dynamics
- 3.1. Rapid Tests Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
- 3.1.1.1. Increasing Adoption Of Self - Testing & Point - Of - Care Products, And Introduction Of CLIA Waived Tests
- 3.1.1.2. Growing Geriatric Population Base
- 3.1.2. Market Challenges
- 3.1.2.1. Presence Of Ambiguous Regulatory
- 3.1.2.2. Reimbursement Framework For Primary Care Setting
- 3.1.3. Market Opportunities
- 3.1.3.1. Introduction Of Advance Technology Enabled Products
- 3.1.3.2. Growing Prevalence Of Target Diseases
Chapter 4. Global Rapid Tests Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.4. Top investment opportunity
- 4.5. Top winning strategies
- 4.6. Industry Experts Prospective
- 4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1. Assessment of the overall impact of COVID-19 on the industry
- 5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Rapid Tests Market, by Product
- 6.1. Market Snapshot
- 6.2. Global Rapid Tests Market by Product, Performance - Potential Analysis
- 6.3. Global Rapid Tests Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
- 6.4. Rapid Tests Market, Sub Segment Analysis
- 6.4.1. Instruments
- 6.4.2. Consumables
- 6.4.3. Others
Chapter 7. Global Rapid Tests Market, by Technology
- 7.1. Market Snapshot
- 7.2. Global Rapid Tests Market by Technology, Performance - Potential Analysis
- 7.3. Global Rapid Tests Market Estimates & Forecasts by Technology 2019-2029 (USD Billion)
- 7.4. Rapid Tests Market, Sub Segment Analysis
- 7.4.1. Molecular Diagnostics
- 7.4.2. Immunoassay
- 7.4.3. Others
Chapter 8. Global Rapid Tests Market, by Application
- 8.1. Market Snapshot
- 8.2. Global Rapid Tests Market by Application, Performance - Potential Analysis
- 8.3. Global Rapid Tests Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
- 8.4. Rapid Tests Market, Sub Segment Analysis
- 8.4.1. Upper Respiratory Tract Infections
- 8.4.2. Antibiotic
- 8.4.3. Sepsis
Chapter 9. Global Rapid Tests Market, by End Use
- 9.1. Market Snapshot
- 9.2. Global Rapid Tests Market by End Use, Performance - Potential Analysis
- 9.3. Global Rapid Tests Market Estimates & Forecasts by End Use 2019-2029 (USD Billion)
- 9.4. Rapid Tests Market, Sub Segment Analysis
- 9.4.1. Hospitals & Clinics
- 9.4.2. Laboratories
- 9.4.3. At - Home Testing
- 9.4.4. Others
Chapter 10. Global Rapid Tests Market, Regional Analysis
- 10.1. Rapid Tests Market, Regional Market Snapshot
- 10.2. North America Rapid Tests Market
- 10.2.1. U.S. Rapid Tests Market
- 10.2.1.1. Product breakdown estimates & forecasts, 2019-2029
- 10.2.1.2. Technology breakdown estimates & forecasts, 2019-2029
- 10.2.1.3. Application breakdown estimates & forecasts, 2019-2029
- 10.2.1.4. End Use breakdown estimates & forecasts, 2019-2029
- 10.2.2. Canada Rapid Tests Market
- 10.3. Europe Rapid Tests Market Snapshot
- 10.3.1. U.K. Rapid Tests Market
- 10.3.2. Germany Rapid Tests Market
- 10.3.3. France Rapid Tests Market
- 10.3.4. Spain Rapid Tests Market
- 10.3.5. Italy Rapid Tests Market
- 10.3.6. Rest of Europe Rapid Tests Market
- 10.4. Asia-Pacific Rapid Tests Market Snapshot
- 10.4.1. China Rapid Tests Market
- 10.4.2. India Rapid Tests Market
- 10.4.3. Japan Rapid Tests Market
- 10.4.4. Australia Rapid Tests Market
- 10.4.5. South Korea Rapid Tests Market
- 10.4.6. Rest of Asia Pacific Rapid Tests Market
- 10.5. Latin America Rapid Tests Market Snapshot
- 10.5.1. Brazil Rapid Tests Market
- 10.5.2. Mexico Rapid Tests Market
- 10.5.3. Rest of Latin America Rapid Tests Market
- 10.6. Rest of The World Rapid Tests Market
Chapter 11. Competitive Intelligence
- 11.1. Top Market Strategies
- 11.2. Company Profiles
- 11.2.1. Abbott
- 11.2.1.1. Key Information
- 11.2.1.2. Overview
- 11.2.1.3. Financial (Subject to Data Availability)
- 11.2.1.4. Product Summary
- 11.2.1.5. Recent Developments
- 11.2.2. BD (Becton, Dickinson and Company)
- 11.2.3. bioMerieux SA
- 11.2.4. DiaSorin S.p.A.
- 11.2.5. Danaher Corporation
- 11.2.6. Thermo Fisher Scientific, Inc.
- 11.2.7. F. Hoffmann - La Roche Ltd
- 11.2.8. Meridian Bioscience, Inc.
- 11.2.9. Bio-rad Laboratories, Inc.
Chapter 12. Research Process
- 12.1. Research Process
- 12.1.1. Data Mining
- 12.1.2. Analysis
- 12.1.3. Market Estimation
- 12.1.4. Validation
- 12.1.5. Publishing
- 12.2. Research Attributes
- 12.3. Research Assumption